BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36736887)

  • 1. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
    Li D; Guo J; Jia R
    J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
    Liu L; Luo C; Luo Y; Chen L; Liu Y; Wang Y; Han J; Zhang Y; Wei N; Xie Z; Wu W; Wu G; Feng Y
    Oncogene; 2018 Jan; 37(1):86-94. PubMed ID: 28869607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
    Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
    J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA LINC00941 Promotes Cell Proliferation and Invasion by Interacting with hnRNPK in Oral Squamous Cell Carcinoma.
    Liu J; Li Z; Zhang T; Wang C; Chen W; Zhang D; Wang J
    Nutr Cancer; 2022; 74(8):2983-2995. PubMed ID: 35037538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
    Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
    Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
    Chen X; Gu P; Xie R; Han J; Liu H; Wang B; Xie W; Xie W; Zhong G; Chen C; Xie S; Jiang N; Lin T; Huang J
    J Cell Mol Med; 2017 Jul; 21(7):1266-1279. PubMed ID: 27862976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
    Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
    Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
    Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
    J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone code reader SPIN1 controls RET signaling in liposarcoma.
    Franz H; Greschik H; Willmann D; Ozretić L; Jilg CA; Wardelmann E; Jung M; Buettner R; Schüle R
    Oncotarget; 2015 Mar; 6(7):4773-89. PubMed ID: 25749382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone code reader SPIN1 is a promising target of cancer therapy.
    Li D; Guo J; Jia R
    Biochimie; 2021 Dec; 191():78-86. PubMed ID: 34492335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
    Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone code reader Spin1 controls skeletal muscle development.
    Greschik H; Duteil D; Messaddeq N; Willmann D; Arrigoni L; Sum M; Jung M; Metzger D; Manke T; Günther T; Schüle R
    Cell Death Dis; 2017 Nov; 8(11):e3173. PubMed ID: 29168801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
    Fu L; Yang M; Ma Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.
    Lee WJ; Shin CH; Ji H; Jeong SD; Park MS; Won HH; Pandey PR; Tsitsipatis D; Gorospe M; Kim HH
    Cell Death Dis; 2021 Mar; 12(4):290. PubMed ID: 33731671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.
    Jia R; Che X; Jia J; Guo J
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.